Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Epkinly
Pharma
EU signs off on Regeneron's T-cell engager for 2 blood cancers
Five months after the FDA rejected Regeneron’s bid for approval of odronextamab, the European Union has signed off on the treatment.
Kevin Dunleavy
Aug 26, 2024 10:35am
Genmab shuffles C-Suite as portfolio grows
Aug 19, 2024 10:08am
AbbVie's Epkinly follows Roche's Lunsumio into FL
Jun 27, 2024 10:21am
AbbVie, Genmab's Epkinly shows promise in follicular lymphoma
Jun 28, 2023 3:08pm
Roche's Columvi nabs FDA nod as 2nd bispecific for DLBCL
Jun 16, 2023 10:49am
AbbVie, Genmab escalate CD20 bispecific battle with FDA nod
May 19, 2023 1:15pm